Workhorse Group Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Workhorse Group Inc. on January 26, 2017, with the earliest event reported on January 26, 2017. The filing primarily announces the entry into a material definitive agreement for an underwritten public offering of common stock and a related conversion agreement.
Key Financial Metrics and Transaction Details
- Offering Size: 6,500,000 shares of common stock at $3.00 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 975,000 additional shares.
- Expected Net Proceeds: Approximately $17.6 million (assuming no exercise of the over-allotment option), after deducting underwriting discounts and estimated offering expenses.
- Convertible Debenture Conversion: $2,000,000 principal amount of 6% Convertible Debenture held by Joseph T. Lukens agreed to be converted into common stock at the offering price.
- Use of Proceeds: Working capital, general corporate purposes, capital expenditures, and research and development.
Material Changes and Recent Developments
The filing discloses a significant capital raise event. The company provided preliminary financial information as of and for the year ended December 31, 2016, in connection with the offering, though specific revenue, profit, or cash flow figures are not detailed in this text. The conversion of the $2.0 million debenture represents a material change in the company's capital structure, reducing debt obligations in exchange for equity.
Guidance, Outlook, and Risks
- Closing Date: The offering is expected to close on or about February 1, 2017, subject to customary closing conditions.
- Lock-Up Period: Directors and executive officers have agreed to a 90-day lock-up period following the date of the final prospectus supplement.
- Risk Factors: The filing includes supplemental risk factors (Exhibit 99.4) which could materially and adversely affect the company's business and financial condition.
- Forward-Looking Statements: The company notes that actual results may differ materially from expectations due to risks such as the ability to satisfy closing conditions.
Investor Verification Checklist
- Verify the final closing date of the offering and whether the over-allotment option was exercised.
- Review the full Prospectus Supplement (Registration Statement No. 333-213100) for detailed financial statements and risk factors.
- Confirm the exact number of shares issued upon the conversion of Joseph T. Lukens' $2.0 million debenture.
- Monitor the company's cash position post-closing to assess the impact of the $17.6 million net proceeds on liquidity.